Literature DB >> 23789017

An unusual presentation of Gaucher disease in an infant with progressive dyspnea.

Joshua M Levy1, Daniel A Glass, Kimsey H Rodriguez.   

Abstract

BACKGROUND: The most common lysosomal storage disorder, Gaucher disease, represents a collection of 3 clinical syndromes associated with disrupted glucocerebroside catabolism. Despite the common occurrence of dyspnea in advanced Gaucher, dyspnea is rarely reported as a presenting symptom of the disease. CASE REPORT: A 10-month-old male was referred to the Otolaryngology Clinic for evaluation of progressive dyspnea. Physical examination was significant for cervical adenopathy, inspiratory stridor, and developmental delay. A complete evaluation for failure to thrive and lymphadenopathy was performed, with subsequent lymph node biopsy and enzyme assay confirming the presence of Gaucher disease.
CONCLUSION: A high level of suspicion is required to make an early diagnosis of Gaucher disease, but it should be considered in patients presenting with failure to thrive, generalized lymphadenopathy, and respiratory or neurologic findings. Initiation of early treatment is paramount for the prevention of irreversible disease.

Entities:  

Keywords:  Gaucher disease; lymphoproliferative diseases; lysosomal storage diseases; respiratory sounds

Year:  2013        PMID: 23789017      PMCID: PMC3684340     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  5 in total

1.  Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

Authors:  T Cox; R Lachmann; C Hollak; J Aerts; S van Weely; M Hrebícek; F Platt; T Butters; R Dwek; C Moyses; I Gow; D Elstein; A Zimran
Journal:  Lancet       Date:  2000-04-29       Impact factor: 79.321

Review 2.  A practical approach to diagnosis and management of Gaucher's disease.

Authors:  P K Mistry; A Abrahamov
Journal:  Baillieres Clin Haematol       Date:  1997-12

3.  A patient with type 2 Gaucher's disease with respiratory disease.

Authors:  Eyman Shebani; Marie Johannesson; Bo Strömberg; Godfried M Roomans
Journal:  J Pediatr       Date:  2003-02       Impact factor: 4.406

Review 4.  Substrate reduction therapy: clinical evaluation in type 1 Gaucher disease.

Authors:  Chris Moyses
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

Review 5.  The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.

Authors:  M Connock; A Burls; E Frew; A Fry-Smith; A Juarez-Garcia; C McCabe; A Wailoo; K Abrams; N Cooper; A Sutton; A O'Hagan; D Moore
Journal:  Health Technol Assess       Date:  2006-07       Impact factor: 4.014

  5 in total
  2 in total

1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2013

2.  Whole-exome Sequencing Helps the Diagnosis and Treatment in Children with Neurodevelopmental Delay Accompanied Unexplained Dyspnea.

Authors:  Wenjia Tong; Yajian Wang; Yun Lu; Tongsheng Ye; Conglei Song; Yuanyuan Xu; Min Li; Jie Ding; Yuanyuan Duan; Le Zhang; Weiyue Gu; Xiaoling Zhao; Xiu-An Yang; Danqun Jin
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.